340B Providers Offer Varying Approaches To Tracking, Using Discounts At Hearing

House Energy and Commerce Committee Chair Greg Walden, R-Ore., expresses frustration at lack of reliable data on the way providers account for 340B drug discounts at Oct. 11 hearing.